HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athira Pharma (ATHA) Investors to Contact Firm's Attorneys Now, Securities Class Action FiledNewsfile Corp • 07/13/21
ATHIRA PHARMA INVESTOR NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit - ATHAPRNewsWire • 07/13/21
ATHA INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc.PRNewsWire • 07/12/21
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Athira Pharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ATHABusiness Wire • 07/10/21
ROSEN, A LEADING LAW FIRM, Encourages Athira Pharma, Inc. Investors With Losses Over $100K to Secure Counsel Before Important August 24 Deadline in Securities Class Action - ATHAPRNewsWire • 07/10/21
SHAREHOLDER ALERT: Robbins LLP Announces that Athira Pharma, Inc. (ATHA) is Being Sued for Misleading ShareholdersBusiness Wire • 07/09/21
ATHA DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important August 24, 2021 Deadline Reminder for Athira Pharma, Inc. InvestorsNewsfile Corp • 07/09/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Advises Athira Pharma (ATHA) Investors to Contact Firm's Attorneys Now, Securities Fraud Lawsuit FiledNewsfile Corp • 07/08/21
ATHA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Athira Pharma, Inc. Investors of Class Action and Encourages Shareholders to Contact the FirmNewsfile Corp • 07/08/21
Athira Pharma Investor Alert: Goldman Scarlato & Penny Investor Rights Lawyers Evaluate Potential Individual, Non-Class Action Claims on Behalf of ATHA InvestorsPRNewsWire • 07/07/21
Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds ATHA Investors for Securities Fraud Class Action LawsuitPRNewsWire • 07/06/21
ATHA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Athira Pharma, Inc. Investors of Class Action and Encourages Shareholders to Contact the FirmBusiness Wire • 07/06/21
Athira Pharma Announces Initiation of Open Label Extension Study for LIFT-AD and ACT-AD Clinical Trials of ATH-1017 for Alzheimer's DiseaseGlobeNewsWire • 07/06/21
Berger Montague Investigates Potential Securities Fraud Claims Against Athira Pharma, Inc. (ATHA); Lead Plaintiff Deadline is August 24, 2021Newsfile Corp • 07/03/21
Athira Pharma Stock: Berger Montague Investigates Securities Fraud Allegations Against Athira Pharma, Inc. (ATHA); Lead Plaintiff Deadline is August 24, 2021Newsfile Corp • 07/02/21
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Athira Pharma, Inc. Investors to Secure Counsel Before Important August 24 Deadline in Securities Class Action – ATHABusiness Wire • 07/02/21
ATHIRA PHARMA, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Western District of Washington against Athira Pharma, Inc.PRNewsWire • 07/01/21
ATHA CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc.Business Wire • 07/01/21
SHAREHOLDER ALERT: Robbins LLP Announces that Athira Pharam, Inc. (ATHA) is Being Sued for Misleading ShareholdersBusiness Wire • 07/01/21
ATHA Stock: Berger Montague Investigates Securities Fraud Claims Against Athira Pharma, Inc. (ATHA); Lead Plaintiff Deadline is August 24, 2021Newsfile Corp • 07/01/21
DEADLINE FOR ATHA INVESTORS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Athira Pharma, Inc.Newsfile Corp • 07/01/21
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc. - ATHAPRNewsWire • 06/30/21
